Please login to the form below

Not currently logged in

Q2 results

This page shows the latest Q2 results news and features for those working in and with pharma, biotech and healthcare.

Merck spin-off Organon sees share price jump at Q2 results

Merck spin-off Organon sees share price jump at Q2 results

Strong growth in women’s health and biosimilars is driving the new company, which expects 2021 growth in the “low to mid-single digit range”

Latest news

More from news
Approximately 19 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Interview: Joseph Jimenez, Novartis Interview: Joseph Jimenez, Novartis

    Our broad, yet focused, portfolio delivered strong results in Q2, with sales growing 19 per cent. ... Consumer health grew five per cent in Q2, largely due to products like Theraflu and Voltaren.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation